Salmonella meningitis: clinical experience of third-generation cephalosporins.
Fifteen paediatric patients with Salmonella meningitis were retrospectively reviewed. Presenting symptoms and signs included fever, vomiting, seizures, poor activity, diarrhoea and bulging anterior fontanelle in most patients. Seven out of eight patients with prolonged fever for > 10 days had neurologic sequelae; therefore, prolonged fever is a significant prognostic factor of a poor outcome (p < 0.005). All 15 patients had a brain ultrasound or computed tomography in the acute stage and 11 patients had abnormal findings. The 14 surviving patients were treated with a third-generation cephalosporin for at least 3 weeks. Seven patients (47%) made complete recoveries; two of them were treated solely with a third-generation cephalosporin. Only one mortality (6%) occurred and there were no relapses. In conclusion, high frequencies of prolonged fever, neuroimaging abnormalities and neurologic sequelae were seen in patients with Salmonella meningitis treated with third-generation cephalosporins.
Huang
L T
LT
Department of Paediatrics, Chang Gung Memorial Hospital, Niao Sung Hsiang, Kaohsiung, Taiwan.
Ko
S F
SF
Lui
C C
CC
D002511:Cephalosporins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology; D011379:Prognosis; D012189:Retrospective Studies; D012480:Salmonella Infections / Q000188:drug therapy*; D016896:Treatment Outcome
D002511:Cephalosporins